ECOLAB INCEE

ECOLAB INC

4,944.53MXND
+97.42+2.01%
At close at Sep 23, 2024, 16:02 GMT
MXN
No trades
See on Supercharts

ECL fundamentals

Key facts

Market capitalization‪1.40 T‬MXN
Founded1923
Employees (FY)‪48 K‬
CEOChristophe Beck
Websiteecolab.com
About

Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Energy and Life Science, and Other. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Other segment is involved in providing services to detect, eliminate and prevent pests. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

Ownership
‪‪283.16 M‬‬
Free Float shares
‪‪253.51 M‬‬ (89.53%)
Closely held shares
‪‪29.65 M‬‬ (10.47%)
Free Float shares
‪‪253.51 M‬‬ (89.53%)
Closely held shares
‪‪29.65 M‬‬ (10.47%)
Capital structure
Market cap
‪‪1.40 T‬‬
Debt
‪‪163.65 B‬‬
Minority interest
‪‪545.79 M‬‬
Cash & equivalents
‪‪24.85 B‬‬
Enterprise value
‪‪1.54 T‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.40 T‬‬
Price to earning ratio (P/E)
32.68x
Price to sales ratio (P/S)
4.34x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
32.68x
Price to sales ratio (P/S)
4.34x
Valuation ratios
‪0.00‬
‪1.20‬
‪2.40‬
‪3.60‬
‪4.80‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪11.00‬
‪22.00‬
‪33.00‬
‪44.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪10.0%‬
‪12.2%‬
‪14.4%‬
‪16.6%‬
‪18.8%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Global Industrial
Global Institutional & Specialty
Global Healthcare & Life Sciences
Other
Corporate
Reconciling Items
By country
Period: 2023
United States
Europe
Asia Pacific
Latin America
Greater China
India, Middle East and Africa
Canada

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪21.00 B‬‬
‪‪42.00 B‬‬
‪‪63.00 B‬‬
‪‪84.00 B‬‬
Actual
Estimate
Earnings
Next:Feb 11, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪10.00‬
‪20.00‬
‪30.00‬
‪40.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
31.98%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.97%
Last payment
13.129
Last ex-date
Dec 17, 2024
Dividend history
‪0.80%‬
‪0.96%‬
‪1.12%‬
‪1.28%‬
‪1.44%‬
2019
2020
2021
2022
2023
‪0.00‬
‪11.00‬
‪22.00‬
‪33.00‬
‪44.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪45.00 B‬‬
‪‪90.00 B‬‬
‪‪135.00 B‬‬
‪‪180.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪80.00 B‬‬
‪‪160.00 B‬‬
‪‪240.00 B‬‬
‪‪320.00 B‬‬
Assets
Liabilities